nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—HTR2B—Raloxifene—osteoporosis	0.2	0.494	CbGbCtD
Cabergoline—CYP3A4—Estropipate—osteoporosis	0.0373	0.0918	CbGbCtD
Cabergoline—CYP3A4—Calcitriol—osteoporosis	0.0373	0.0918	CbGbCtD
Cabergoline—CYP3A4—Ergocalciferol—osteoporosis	0.0298	0.0734	CbGbCtD
Cabergoline—CYP3A4—Raloxifene—osteoporosis	0.0249	0.0613	CbGbCtD
Cabergoline—CYP3A4—Ethinyl Estradiol—osteoporosis	0.024	0.0592	CbGbCtD
Cabergoline—CYP3A4—Cholecalciferol—osteoporosis	0.0192	0.0473	CbGbCtD
Cabergoline—CYP3A4—Conjugated Estrogens—osteoporosis	0.0176	0.0434	CbGbCtD
Cabergoline—CYP3A4—Estradiol—osteoporosis	0.0155	0.0381	CbGbCtD
Cabergoline—Nervousness—Conjugated Estrogens—osteoporosis	0.000469	0.00107	CcSEcCtD
Cabergoline—Gastrointestinal pain—Ibandronate—osteoporosis	0.000468	0.00107	CcSEcCtD
Cabergoline—Arthralgia—Pamidronate—osteoporosis	0.000467	0.00107	CcSEcCtD
Cabergoline—Back pain—Conjugated Estrogens—osteoporosis	0.000467	0.00107	CcSEcCtD
Cabergoline—Epistaxis—Estradiol—osteoporosis	0.000466	0.00107	CcSEcCtD
Cabergoline—Anxiety—Pamidronate—osteoporosis	0.000466	0.00107	CcSEcCtD
Cabergoline—Ill-defined disorder—Zoledronate—osteoporosis	0.000465	0.00106	CcSEcCtD
Cabergoline—Abdominal pain—Alendronate—osteoporosis	0.000464	0.00106	CcSEcCtD
Cabergoline—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000464	0.00106	CcSEcCtD
Cabergoline—Shock—Risedronate—osteoporosis	0.000464	0.00106	CcSEcCtD
Cabergoline—Discomfort—Pamidronate—osteoporosis	0.000462	0.00106	CcSEcCtD
Cabergoline—Gastrointestinal pain—Calcitriol—osteoporosis	0.000458	0.00105	CcSEcCtD
Cabergoline—Abdominal pain—Raloxifene—osteoporosis	0.000457	0.00104	CcSEcCtD
Cabergoline—Malaise—Zoledronate—osteoporosis	0.000452	0.00103	CcSEcCtD
Cabergoline—Abdominal pain—Ibandronate—osteoporosis	0.000452	0.00103	CcSEcCtD
Cabergoline—Confusional state—Pamidronate—osteoporosis	0.000452	0.00103	CcSEcCtD
Cabergoline—Vertigo—Zoledronate—osteoporosis	0.000451	0.00103	CcSEcCtD
Cabergoline—Syncope—Zoledronate—osteoporosis	0.00045	0.00103	CcSEcCtD
Cabergoline—Oedema—Pamidronate—osteoporosis	0.000448	0.00103	CcSEcCtD
Cabergoline—Rhinitis—Estradiol—osteoporosis	0.000445	0.00102	CcSEcCtD
Cabergoline—Palpitations—Zoledronate—osteoporosis	0.000443	0.00101	CcSEcCtD
Cabergoline—Abdominal pain—Calcitriol—osteoporosis	0.000443	0.00101	CcSEcCtD
Cabergoline—Shock—Pamidronate—osteoporosis	0.000441	0.00101	CcSEcCtD
Cabergoline—Loss of consciousness—Zoledronate—osteoporosis	0.000441	0.00101	CcSEcCtD
Cabergoline—Hypersensitivity—Estropipate—osteoporosis	0.000439	0.00101	CcSEcCtD
Cabergoline—Vomiting—Etidronic acid—osteoporosis	0.000438	0.001	CcSEcCtD
Cabergoline—Oedema peripheral—Estradiol—osteoporosis	0.000437	0.001	CcSEcCtD
Cabergoline—Rash—Etidronic acid—osteoporosis	0.000435	0.000995	CcSEcCtD
Cabergoline—Dermatitis—Etidronic acid—osteoporosis	0.000434	0.000994	CcSEcCtD
Cabergoline—Vertigo—Conjugated Estrogens—osteoporosis	0.000434	0.000993	CcSEcCtD
Cabergoline—Hyperhidrosis—Pamidronate—osteoporosis	0.000433	0.000991	CcSEcCtD
Cabergoline—Syncope—Conjugated Estrogens—osteoporosis	0.000433	0.000991	CcSEcCtD
Cabergoline—Hypertension—Zoledronate—osteoporosis	0.000433	0.000991	CcSEcCtD
Cabergoline—Hypersensitivity—Alendronate—osteoporosis	0.000433	0.00099	CcSEcCtD
Cabergoline—Headache—Etidronic acid—osteoporosis	0.000432	0.000988	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000429	0.000983	CcSEcCtD
Cabergoline—Asthenia—Estropipate—osteoporosis	0.000428	0.000979	CcSEcCtD
Cabergoline—Visual impairment—Estradiol—osteoporosis	0.000428	0.000979	CcSEcCtD
Cabergoline—Anorexia—Pamidronate—osteoporosis	0.000427	0.000977	CcSEcCtD
Cabergoline—Arthralgia—Zoledronate—osteoporosis	0.000427	0.000977	CcSEcCtD
Cabergoline—Palpitations—Conjugated Estrogens—osteoporosis	0.000427	0.000976	CcSEcCtD
Cabergoline—Insomnia—Risedronate—osteoporosis	0.000426	0.000975	CcSEcCtD
Cabergoline—Anxiety—Zoledronate—osteoporosis	0.000425	0.000973	CcSEcCtD
Cabergoline—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000424	0.000971	CcSEcCtD
Cabergoline—Paraesthesia—Risedronate—osteoporosis	0.000423	0.000968	CcSEcCtD
Cabergoline—Pruritus—Estropipate—osteoporosis	0.000422	0.000965	CcSEcCtD
Cabergoline—Discomfort—Zoledronate—osteoporosis	0.000422	0.000965	CcSEcCtD
Cabergoline—Asthenia—Alendronate—osteoporosis	0.000421	0.000964	CcSEcCtD
Cabergoline—Hypersensitivity—Ibandronate—osteoporosis	0.000421	0.000964	CcSEcCtD
Cabergoline—Dyspnoea—Risedronate—osteoporosis	0.00042	0.000961	CcSEcCtD
Cabergoline—Hypotension—Pamidronate—osteoporosis	0.000419	0.000958	CcSEcCtD
Cabergoline—Dry mouth—Zoledronate—osteoporosis	0.000418	0.000955	CcSEcCtD
Cabergoline—Fatigue—Ethinyl Estradiol—osteoporosis	0.000417	0.000954	CcSEcCtD
Cabergoline—Pruritus—Alendronate—osteoporosis	0.000416	0.000951	CcSEcCtD
Cabergoline—Dyspepsia—Risedronate—osteoporosis	0.000415	0.000949	CcSEcCtD
Cabergoline—Constipation—Ethinyl Estradiol—osteoporosis	0.000413	0.000946	CcSEcCtD
Cabergoline—Confusional state—Zoledronate—osteoporosis	0.000413	0.000944	CcSEcCtD
Cabergoline—Hypersensitivity—Calcitriol—osteoporosis	0.000412	0.000944	CcSEcCtD
Cabergoline—Cardiac disorder—Estradiol—osteoporosis	0.000412	0.000943	CcSEcCtD
Cabergoline—Arthralgia—Conjugated Estrogens—osteoporosis	0.000411	0.000941	CcSEcCtD
Cabergoline—Asthenia—Ibandronate—osteoporosis	0.00041	0.000939	CcSEcCtD
Cabergoline—Anxiety—Conjugated Estrogens—osteoporosis	0.00041	0.000937	CcSEcCtD
Cabergoline—Nausea—Etidronic acid—osteoporosis	0.000409	0.000937	CcSEcCtD
Cabergoline—Oedema—Zoledronate—osteoporosis	0.000409	0.000936	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000408	0.000934	CcSEcCtD
Cabergoline—Diarrhoea—Estropipate—osteoporosis	0.000408	0.000934	CcSEcCtD
Cabergoline—Fatigue—Risedronate—osteoporosis	0.000406	0.00093	CcSEcCtD
Cabergoline—Insomnia—Pamidronate—osteoporosis	0.000405	0.000927	CcSEcCtD
Cabergoline—Pruritus—Ibandronate—osteoporosis	0.000405	0.000926	CcSEcCtD
Cabergoline—Constipation—Risedronate—osteoporosis	0.000403	0.000922	CcSEcCtD
Cabergoline—Pain—Risedronate—osteoporosis	0.000403	0.000922	CcSEcCtD
Cabergoline—Shock—Zoledronate—osteoporosis	0.000403	0.000921	CcSEcCtD
Cabergoline—Paraesthesia—Pamidronate—osteoporosis	0.000402	0.000921	CcSEcCtD
Cabergoline—Diarrhoea—Alendronate—osteoporosis	0.000402	0.00092	CcSEcCtD
Cabergoline—Asthenia—Calcitriol—osteoporosis	0.000402	0.000919	CcSEcCtD
Cabergoline—Dyspnoea—Pamidronate—osteoporosis	0.000399	0.000914	CcSEcCtD
Cabergoline—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000398	0.000912	CcSEcCtD
Cabergoline—Somnolence—Pamidronate—osteoporosis	0.000398	0.000911	CcSEcCtD
Cabergoline—Pruritus—Calcitriol—osteoporosis	0.000396	0.000906	CcSEcCtD
Cabergoline—Hyperhidrosis—Zoledronate—osteoporosis	0.000396	0.000905	CcSEcCtD
Cabergoline—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000395	0.000905	CcSEcCtD
Cabergoline—Diarrhoea—Raloxifene—osteoporosis	0.000395	0.000904	CcSEcCtD
Cabergoline—Dyspepsia—Pamidronate—osteoporosis	0.000394	0.000902	CcSEcCtD
Cabergoline—Dizziness—Estropipate—osteoporosis	0.000394	0.000902	CcSEcCtD
Cabergoline—Oedema—Conjugated Estrogens—osteoporosis	0.000394	0.000902	CcSEcCtD
Cabergoline—Alopecia—Estradiol—osteoporosis	0.000392	0.000898	CcSEcCtD
Cabergoline—Diarrhoea—Ibandronate—osteoporosis	0.000391	0.000895	CcSEcCtD
Cabergoline—Anorexia—Zoledronate—osteoporosis	0.00039	0.000893	CcSEcCtD
Cabergoline—Decreased appetite—Pamidronate—osteoporosis	0.000389	0.000891	CcSEcCtD
Cabergoline—Dizziness—Alendronate—osteoporosis	0.000388	0.000889	CcSEcCtD
Cabergoline—Shock—Conjugated Estrogens—osteoporosis	0.000388	0.000887	CcSEcCtD
Cabergoline—Fatigue—Pamidronate—osteoporosis	0.000386	0.000884	CcSEcCtD
Cabergoline—Gastrointestinal pain—Risedronate—osteoporosis	0.000385	0.000882	CcSEcCtD
Cabergoline—Pain—Pamidronate—osteoporosis	0.000383	0.000877	CcSEcCtD
Cabergoline—Constipation—Pamidronate—osteoporosis	0.000383	0.000877	CcSEcCtD
Cabergoline—Diarrhoea—Calcitriol—osteoporosis	0.000383	0.000876	CcSEcCtD
Cabergoline—Hypotension—Zoledronate—osteoporosis	0.000382	0.000875	CcSEcCtD
Cabergoline—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000382	0.000874	CcSEcCtD
Cabergoline—Dizziness—Raloxifene—osteoporosis	0.000382	0.000874	CcSEcCtD
Cabergoline—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000381	0.000872	CcSEcCtD
Cabergoline—Flatulence—Estradiol—osteoporosis	0.000381	0.000871	CcSEcCtD
Cabergoline—Tension—Estradiol—osteoporosis	0.000379	0.000868	CcSEcCtD
Cabergoline—Vomiting—Estropipate—osteoporosis	0.000379	0.000868	CcSEcCtD
Cabergoline—Dizziness—Ibandronate—osteoporosis	0.000378	0.000865	CcSEcCtD
Cabergoline—Rash—Estropipate—osteoporosis	0.000376	0.00086	CcSEcCtD
Cabergoline—Dermatitis—Estropipate—osteoporosis	0.000376	0.00086	CcSEcCtD
Cabergoline—Anorexia—Conjugated Estrogens—osteoporosis	0.000376	0.00086	CcSEcCtD
Cabergoline—Nervousness—Estradiol—osteoporosis	0.000375	0.000859	CcSEcCtD
Cabergoline—Back pain—Estradiol—osteoporosis	0.000374	0.000855	CcSEcCtD
Cabergoline—Headache—Estropipate—osteoporosis	0.000374	0.000855	CcSEcCtD
Cabergoline—Vomiting—Alendronate—osteoporosis	0.000373	0.000855	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000373	0.000853	CcSEcCtD
Cabergoline—Abdominal pain—Risedronate—osteoporosis	0.000373	0.000853	CcSEcCtD
Cabergoline—Muscle spasms—Estradiol—osteoporosis	0.000372	0.00085	CcSEcCtD
Cabergoline—Rash—Alendronate—osteoporosis	0.00037	0.000847	CcSEcCtD
Cabergoline—Insomnia—Zoledronate—osteoporosis	0.00037	0.000847	CcSEcCtD
Cabergoline—Dermatitis—Alendronate—osteoporosis	0.00037	0.000847	CcSEcCtD
Cabergoline—Feeling abnormal—Pamidronate—osteoporosis	0.000369	0.000845	CcSEcCtD
Cabergoline—Hypotension—Conjugated Estrogens—osteoporosis	0.000368	0.000843	CcSEcCtD
Cabergoline—Headache—Alendronate—osteoporosis	0.000368	0.000842	CcSEcCtD
Cabergoline—Paraesthesia—Zoledronate—osteoporosis	0.000368	0.000841	CcSEcCtD
Cabergoline—Vomiting—Raloxifene—osteoporosis	0.000367	0.00084	CcSEcCtD
Cabergoline—Gastrointestinal pain—Pamidronate—osteoporosis	0.000366	0.000838	CcSEcCtD
Cabergoline—Dyspnoea—Zoledronate—osteoporosis	0.000365	0.000835	CcSEcCtD
Cabergoline—Rash—Raloxifene—osteoporosis	0.000364	0.000833	CcSEcCtD
Cabergoline—Dermatitis—Raloxifene—osteoporosis	0.000364	0.000833	CcSEcCtD
Cabergoline—Somnolence—Zoledronate—osteoporosis	0.000364	0.000833	CcSEcCtD
Cabergoline—Vomiting—Ibandronate—osteoporosis	0.000364	0.000832	CcSEcCtD
Cabergoline—Headache—Raloxifene—osteoporosis	0.000362	0.000828	CcSEcCtD
Cabergoline—Rash—Ibandronate—osteoporosis	0.000361	0.000825	CcSEcCtD
Cabergoline—Dermatitis—Ibandronate—osteoporosis	0.00036	0.000824	CcSEcCtD
Cabergoline—Dyspepsia—Zoledronate—osteoporosis	0.00036	0.000824	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000359	0.000822	CcSEcCtD
Cabergoline—Ill-defined disorder—Estradiol—osteoporosis	0.000359	0.00082	CcSEcCtD
Cabergoline—Headache—Ibandronate—osteoporosis	0.000358	0.00082	CcSEcCtD
Cabergoline—Insomnia—Conjugated Estrogens—osteoporosis	0.000356	0.000816	CcSEcCtD
Cabergoline—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000356	0.000815	CcSEcCtD
Cabergoline—Vomiting—Calcitriol—osteoporosis	0.000356	0.000814	CcSEcCtD
Cabergoline—Decreased appetite—Zoledronate—osteoporosis	0.000356	0.000814	CcSEcCtD
Cabergoline—Nausea—Estropipate—osteoporosis	0.000354	0.000811	CcSEcCtD
Cabergoline—Abdominal pain—Pamidronate—osteoporosis	0.000354	0.00081	CcSEcCtD
Cabergoline—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000354	0.00081	CcSEcCtD
Cabergoline—Rash—Calcitriol—osteoporosis	0.000353	0.000808	CcSEcCtD
Cabergoline—Fatigue—Zoledronate—osteoporosis	0.000353	0.000807	CcSEcCtD
Cabergoline—Dermatitis—Calcitriol—osteoporosis	0.000353	0.000807	CcSEcCtD
Cabergoline—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000351	0.000804	CcSEcCtD
Cabergoline—Headache—Calcitriol—osteoporosis	0.000351	0.000803	CcSEcCtD
Cabergoline—Somnolence—Conjugated Estrogens—osteoporosis	0.00035	0.000802	CcSEcCtD
Cabergoline—Constipation—Zoledronate—osteoporosis	0.00035	0.000801	CcSEcCtD
Cabergoline—Pain—Zoledronate—osteoporosis	0.00035	0.000801	CcSEcCtD
Cabergoline—Nausea—Alendronate—osteoporosis	0.000349	0.000798	CcSEcCtD
Cabergoline—Malaise—Estradiol—osteoporosis	0.000349	0.000797	CcSEcCtD
Cabergoline—Hypersensitivity—Risedronate—osteoporosis	0.000347	0.000795	CcSEcCtD
Cabergoline—Vertigo—Estradiol—osteoporosis	0.000347	0.000794	CcSEcCtD
Cabergoline—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000347	0.000794	CcSEcCtD
Cabergoline—Asthenia—Ethinyl Estradiol—osteoporosis	0.000347	0.000794	CcSEcCtD
Cabergoline—Syncope—Estradiol—osteoporosis	0.000347	0.000793	CcSEcCtD
Cabergoline—Nausea—Raloxifene—osteoporosis	0.000343	0.000785	CcSEcCtD
Cabergoline—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000343	0.000784	CcSEcCtD
Cabergoline—Pruritus—Ethinyl Estradiol—osteoporosis	0.000342	0.000783	CcSEcCtD
Cabergoline—Palpitations—Estradiol—osteoporosis	0.000342	0.000781	CcSEcCtD
Cabergoline—Fatigue—Conjugated Estrogens—osteoporosis	0.00034	0.000777	CcSEcCtD
Cabergoline—Nausea—Ibandronate—osteoporosis	0.00034	0.000777	CcSEcCtD
Cabergoline—Loss of consciousness—Estradiol—osteoporosis	0.00034	0.000777	CcSEcCtD
Cabergoline—Asthenia—Risedronate—osteoporosis	0.000338	0.000774	CcSEcCtD
Cabergoline—Feeling abnormal—Zoledronate—osteoporosis	0.000337	0.000772	CcSEcCtD
Cabergoline—Pain—Conjugated Estrogens—osteoporosis	0.000337	0.000771	CcSEcCtD
Cabergoline—Constipation—Conjugated Estrogens—osteoporosis	0.000337	0.000771	CcSEcCtD
Cabergoline—Gastrointestinal pain—Zoledronate—osteoporosis	0.000335	0.000766	CcSEcCtD
Cabergoline—Hypertension—Estradiol—osteoporosis	0.000334	0.000763	CcSEcCtD
Cabergoline—Pruritus—Risedronate—osteoporosis	0.000333	0.000763	CcSEcCtD
Cabergoline—Nausea—Calcitriol—osteoporosis	0.000333	0.000761	CcSEcCtD
Cabergoline—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000331	0.000757	CcSEcCtD
Cabergoline—Hypersensitivity—Pamidronate—osteoporosis	0.00033	0.000755	CcSEcCtD
Cabergoline—Arthralgia—Estradiol—osteoporosis	0.000329	0.000753	CcSEcCtD
Cabergoline—Anxiety—Estradiol—osteoporosis	0.000328	0.00075	CcSEcCtD
Cabergoline—Discomfort—Estradiol—osteoporosis	0.000325	0.000744	CcSEcCtD
Cabergoline—Abdominal pain—Zoledronate—osteoporosis	0.000324	0.00074	CcSEcCtD
Cabergoline—Diarrhoea—Risedronate—osteoporosis	0.000322	0.000738	CcSEcCtD
Cabergoline—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000322	0.000737	CcSEcCtD
Cabergoline—Dry mouth—Estradiol—osteoporosis	0.000322	0.000736	CcSEcCtD
Cabergoline—Asthenia—Pamidronate—osteoporosis	0.000321	0.000736	CcSEcCtD
Cabergoline—Dizziness—Ethinyl Estradiol—osteoporosis	0.00032	0.000731	CcSEcCtD
Cabergoline—Confusional state—Estradiol—osteoporosis	0.000318	0.000728	CcSEcCtD
Cabergoline—Pruritus—Pamidronate—osteoporosis	0.000317	0.000725	CcSEcCtD
Cabergoline—Oedema—Estradiol—osteoporosis	0.000315	0.000722	CcSEcCtD
Cabergoline—Dizziness—Risedronate—osteoporosis	0.000312	0.000713	CcSEcCtD
Cabergoline—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000312	0.000713	CcSEcCtD
Cabergoline—Shock—Estradiol—osteoporosis	0.00031	0.00071	CcSEcCtD
Cabergoline—Vomiting—Ethinyl Estradiol—osteoporosis	0.000307	0.000703	CcSEcCtD
Cabergoline—Diarrhoea—Pamidronate—osteoporosis	0.000307	0.000701	CcSEcCtD
Cabergoline—Hyperhidrosis—Estradiol—osteoporosis	0.000305	0.000698	CcSEcCtD
Cabergoline—Rash—Ethinyl Estradiol—osteoporosis	0.000305	0.000697	CcSEcCtD
Cabergoline—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000305	0.000697	CcSEcCtD
Cabergoline—Headache—Ethinyl Estradiol—osteoporosis	0.000303	0.000693	CcSEcCtD
Cabergoline—Hypersensitivity—Zoledronate—osteoporosis	0.000302	0.00069	CcSEcCtD
Cabergoline—Vomiting—Risedronate—osteoporosis	0.0003	0.000686	CcSEcCtD
Cabergoline—Rash—Risedronate—osteoporosis	0.000297	0.00068	CcSEcCtD
Cabergoline—Dermatitis—Risedronate—osteoporosis	0.000297	0.000679	CcSEcCtD
Cabergoline—Dizziness—Pamidronate—osteoporosis	0.000296	0.000678	CcSEcCtD
Cabergoline—Headache—Risedronate—osteoporosis	0.000295	0.000676	CcSEcCtD
Cabergoline—Asthenia—Zoledronate—osteoporosis	0.000294	0.000672	CcSEcCtD
Cabergoline—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00029	0.000664	CcSEcCtD
Cabergoline—Pruritus—Zoledronate—osteoporosis	0.00029	0.000663	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000287	0.000657	CcSEcCtD
Cabergoline—Nausea—Ethinyl Estradiol—osteoporosis	0.000287	0.000657	CcSEcCtD
Cabergoline—Insomnia—Estradiol—osteoporosis	0.000285	0.000653	CcSEcCtD
Cabergoline—Vomiting—Pamidronate—osteoporosis	0.000285	0.000652	CcSEcCtD
Cabergoline—Paraesthesia—Estradiol—osteoporosis	0.000283	0.000648	CcSEcCtD
Cabergoline—Asthenia—Conjugated Estrogens—osteoporosis	0.000283	0.000647	CcSEcCtD
Cabergoline—Rash—Pamidronate—osteoporosis	0.000283	0.000646	CcSEcCtD
Cabergoline—Dermatitis—Pamidronate—osteoporosis	0.000282	0.000646	CcSEcCtD
Cabergoline—Dyspnoea—Estradiol—osteoporosis	0.000281	0.000643	CcSEcCtD
Cabergoline—Headache—Pamidronate—osteoporosis	0.000281	0.000642	CcSEcCtD
Cabergoline—Somnolence—Estradiol—osteoporosis	0.00028	0.000642	CcSEcCtD
Cabergoline—Diarrhoea—Zoledronate—osteoporosis	0.00028	0.000641	CcSEcCtD
Cabergoline—Nausea—Risedronate—osteoporosis	0.00028	0.000641	CcSEcCtD
Cabergoline—Pruritus—Conjugated Estrogens—osteoporosis	0.000279	0.000638	CcSEcCtD
Cabergoline—Dyspepsia—Estradiol—osteoporosis	0.000278	0.000635	CcSEcCtD
Cabergoline—Decreased appetite—Estradiol—osteoporosis	0.000274	0.000627	CcSEcCtD
Cabergoline—Fatigue—Estradiol—osteoporosis	0.000272	0.000622	CcSEcCtD
Cabergoline—Dizziness—Zoledronate—osteoporosis	0.000271	0.000619	CcSEcCtD
Cabergoline—Pain—Estradiol—osteoporosis	0.00027	0.000617	CcSEcCtD
Cabergoline—Constipation—Estradiol—osteoporosis	0.00027	0.000617	CcSEcCtD
Cabergoline—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00027	0.000617	CcSEcCtD
Cabergoline—Nausea—Pamidronate—osteoporosis	0.000266	0.000609	CcSEcCtD
Cabergoline—Dizziness—Conjugated Estrogens—osteoporosis	0.000261	0.000596	CcSEcCtD
Cabergoline—Vomiting—Zoledronate—osteoporosis	0.00026	0.000595	CcSEcCtD
Cabergoline—Feeling abnormal—Estradiol—osteoporosis	0.00026	0.000595	CcSEcCtD
Cabergoline—Rash—Zoledronate—osteoporosis	0.000258	0.00059	CcSEcCtD
Cabergoline—Gastrointestinal pain—Estradiol—osteoporosis	0.000258	0.00059	CcSEcCtD
Cabergoline—Dermatitis—Zoledronate—osteoporosis	0.000258	0.00059	CcSEcCtD
Cabergoline—Headache—Zoledronate—osteoporosis	0.000256	0.000587	CcSEcCtD
Cabergoline—Vomiting—Conjugated Estrogens—osteoporosis	0.000251	0.000573	CcSEcCtD
Cabergoline—Abdominal pain—Estradiol—osteoporosis	0.000249	0.00057	CcSEcCtD
Cabergoline—Rash—Conjugated Estrogens—osteoporosis	0.000248	0.000569	CcSEcCtD
Cabergoline—Dermatitis—Conjugated Estrogens—osteoporosis	0.000248	0.000568	CcSEcCtD
Cabergoline—Headache—Conjugated Estrogens—osteoporosis	0.000247	0.000565	CcSEcCtD
Cabergoline—Nausea—Zoledronate—osteoporosis	0.000243	0.000556	CcSEcCtD
Cabergoline—Nausea—Conjugated Estrogens—osteoporosis	0.000234	0.000536	CcSEcCtD
Cabergoline—Hypersensitivity—Estradiol—osteoporosis	0.000232	0.000532	CcSEcCtD
Cabergoline—Asthenia—Estradiol—osteoporosis	0.000226	0.000518	CcSEcCtD
Cabergoline—Pruritus—Estradiol—osteoporosis	0.000223	0.000511	CcSEcCtD
Cabergoline—Diarrhoea—Estradiol—osteoporosis	0.000216	0.000494	CcSEcCtD
Cabergoline—Dizziness—Estradiol—osteoporosis	0.000209	0.000477	CcSEcCtD
Cabergoline—Vomiting—Estradiol—osteoporosis	0.000201	0.000459	CcSEcCtD
Cabergoline—Rash—Estradiol—osteoporosis	0.000199	0.000455	CcSEcCtD
Cabergoline—Dermatitis—Estradiol—osteoporosis	0.000199	0.000455	CcSEcCtD
Cabergoline—Headache—Estradiol—osteoporosis	0.000198	0.000452	CcSEcCtD
Cabergoline—Nausea—Estradiol—osteoporosis	0.000187	0.000429	CcSEcCtD
Cabergoline—DRD4—Signaling Pathways—ESR1—osteoporosis	2.05e-05	0.000131	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—LEP—osteoporosis	2.05e-05	0.000131	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—POMC—osteoporosis	2.05e-05	0.00013	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—IL6R—osteoporosis	2.04e-05	0.00013	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—ADCY5—osteoporosis	2.03e-05	0.000129	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	2.01e-05	0.000128	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—IRS1—osteoporosis	2e-05	0.000128	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	2e-05	0.000127	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—IRS1—osteoporosis	1.99e-05	0.000127	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—ADCY5—osteoporosis	1.99e-05	0.000127	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IRS2—osteoporosis	1.98e-05	0.000126	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—SPP1—osteoporosis	1.97e-05	0.000125	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—ESR1—osteoporosis	1.96e-05	0.000125	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IRS2—osteoporosis	1.95e-05	0.000124	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IRS2—osteoporosis	1.95e-05	0.000124	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—KL—osteoporosis	1.95e-05	0.000124	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—IRS1—osteoporosis	1.95e-05	0.000124	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—SPP1—osteoporosis	1.95e-05	0.000124	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.94e-05	0.000124	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—LEP—osteoporosis	1.93e-05	0.000123	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.93e-05	0.000123	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—POMC—osteoporosis	1.93e-05	0.000123	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—IDH2—osteoporosis	1.93e-05	0.000123	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—SPP1—osteoporosis	1.92e-05	0.000123	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—IRS1—osteoporosis	1.92e-05	0.000122	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—POMC—osteoporosis	1.92e-05	0.000122	CbGpPWpGaD
Cabergoline—ADRA2A—Hemostasis—TGFB1—osteoporosis	1.91e-05	0.000122	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—LEP—osteoporosis	1.91e-05	0.000122	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—LEP—osteoporosis	1.91e-05	0.000122	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—POMC—osteoporosis	1.9e-05	0.000121	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—IL6R—osteoporosis	1.88e-05	0.00012	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	1.88e-05	0.00012	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.88e-05	0.00012	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—POMC—osteoporosis	1.88e-05	0.00012	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.87e-05	0.000119	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—IL6R—osteoporosis	1.87e-05	0.000119	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—IGF1—osteoporosis	1.85e-05	0.000118	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	1.85e-05	0.000118	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	1.85e-05	0.000118	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—ESR1—osteoporosis	1.85e-05	0.000118	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—POMC—osteoporosis	1.85e-05	0.000118	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—IGF1—osteoporosis	1.84e-05	0.000117	CbGpPWpGaD
Cabergoline—DRD5—Signaling by GPCR—IL6—osteoporosis	1.84e-05	0.000117	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—IRS1—osteoporosis	1.83e-05	0.000117	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—IL6R—osteoporosis	1.83e-05	0.000117	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—ADCY5—osteoporosis	1.83e-05	0.000116	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—ESR1—osteoporosis	1.82e-05	0.000116	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—ESR1—osteoporosis	1.82e-05	0.000116	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—GPX1—osteoporosis	1.82e-05	0.000116	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—SPP1—osteoporosis	1.82e-05	0.000116	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.81e-05	0.000116	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—IGF1—osteoporosis	1.8e-05	0.000115	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—IL6R—osteoporosis	1.8e-05	0.000115	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—SPP1—osteoporosis	1.79e-05	0.000114	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IRS2—osteoporosis	1.78e-05	0.000113	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—IGF1—osteoporosis	1.78e-05	0.000113	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ACP5—osteoporosis	1.76e-05	0.000112	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—POMC—osteoporosis	1.76e-05	0.000112	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IRS2—osteoporosis	1.76e-05	0.000112	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—LEP—osteoporosis	1.74e-05	0.000111	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IRS2—osteoporosis	1.74e-05	0.000111	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IRS1—osteoporosis	1.73e-05	0.00011	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—LEP—osteoporosis	1.72e-05	0.00011	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—IL6R—osteoporosis	1.72e-05	0.00011	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.71e-05	0.000109	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IRS1—osteoporosis	1.7e-05	0.000109	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IRS1—osteoporosis	1.7e-05	0.000109	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—LEP—osteoporosis	1.7e-05	0.000108	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.7e-05	0.000108	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—IGF1—osteoporosis	1.7e-05	0.000108	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.69e-05	0.000108	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—MTHFR—osteoporosis	1.68e-05	0.000107	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.68e-05	0.000107	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—LEP—osteoporosis	1.66e-05	0.000106	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—POMC—osteoporosis	1.66e-05	0.000106	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—ESR1—osteoporosis	1.66e-05	0.000106	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—LEP—osteoporosis	1.65e-05	0.000105	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—POMC—osteoporosis	1.65e-05	0.000105	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—SPP1—osteoporosis	1.65e-05	0.000105	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—ESR1—osteoporosis	1.65e-05	0.000105	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IRS2—osteoporosis	1.64e-05	0.000105	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	1.64e-05	0.000105	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—POMC—osteoporosis	1.64e-05	0.000105	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—POMC—osteoporosis	1.64e-05	0.000105	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—TPI1—osteoporosis	1.64e-05	0.000104	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—ESR1—osteoporosis	1.62e-05	0.000104	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.62e-05	0.000104	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IL6R—osteoporosis	1.62e-05	0.000103	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IRS2—osteoporosis	1.62e-05	0.000103	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—LEP—osteoporosis	1.61e-05	0.000103	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IL6R—osteoporosis	1.6e-05	0.000102	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IL6R—osteoporosis	1.6e-05	0.000102	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IGF1—osteoporosis	1.6e-05	0.000102	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—SPP1—osteoporosis	1.59e-05	0.000101	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.59e-05	0.000101	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—LEP—osteoporosis	1.58e-05	0.000101	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.58e-05	0.000101	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IGF1—osteoporosis	1.58e-05	0.000101	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IGF1—osteoporosis	1.58e-05	0.000101	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IRS1—osteoporosis	1.55e-05	9.89e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—P4HB—osteoporosis	1.54e-05	9.82e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IRS1—osteoporosis	1.54e-05	9.8e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—ESR1—osteoporosis	1.54e-05	9.8e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	1.53e-05	9.73e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IRS1—osteoporosis	1.52e-05	9.67e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GAPDH—osteoporosis	1.51e-05	9.64e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—ESR1—osteoporosis	1.51e-05	9.64e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—POMC—osteoporosis	1.49e-05	9.52e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IRS2—osteoporosis	1.49e-05	9.51e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.48e-05	9.46e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—POMC—osteoporosis	1.48e-05	9.44e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1.48e-05	9.42e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.48e-05	9.41e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—RAP1A—osteoporosis	1.47e-05	9.39e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.47e-05	9.36e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—POMC—osteoporosis	1.46e-05	9.32e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—LEP—osteoporosis	1.46e-05	9.31e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IL6R—osteoporosis	1.46e-05	9.29e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—MYC—osteoporosis	1.45e-05	9.22e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IL6R—osteoporosis	1.44e-05	9.2e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—TGFB1—osteoporosis	1.44e-05	9.19e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IRS2—osteoporosis	1.44e-05	9.17e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—LEP—osteoporosis	1.44e-05	9.16e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IGF1—osteoporosis	1.44e-05	9.16e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IRS1—osteoporosis	1.44e-05	9.15e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—POMC—osteoporosis	1.43e-05	9.11e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IL6R—osteoporosis	1.43e-05	9.09e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IGF1—osteoporosis	1.42e-05	9.08e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—POMC—osteoporosis	1.42e-05	9.06e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—IL6—osteoporosis	1.42e-05	9.04e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IRS1—osteoporosis	1.41e-05	9.01e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—IL6—osteoporosis	1.41e-05	8.98e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—LEP—osteoporosis	1.41e-05	8.97e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IGF1—osteoporosis	1.41e-05	8.96e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—ESR1—osteoporosis	1.39e-05	8.89e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IL6R—osteoporosis	1.39e-05	8.89e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IL6R—osteoporosis	1.39e-05	8.84e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—POMC—osteoporosis	1.38e-05	8.81e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—IL6—osteoporosis	1.38e-05	8.8e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IGF1—osteoporosis	1.37e-05	8.76e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—ESR1—osteoporosis	1.37e-05	8.75e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IGF1—osteoporosis	1.37e-05	8.72e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—POMC—osteoporosis	1.36e-05	8.67e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—IL6—osteoporosis	1.36e-05	8.66e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IL6R—osteoporosis	1.35e-05	8.6e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—ESR1—osteoporosis	1.34e-05	8.56e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—POMC—osteoporosis	1.34e-05	8.56e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IRS2—osteoporosis	1.34e-05	8.52e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IGF1—osteoporosis	1.33e-05	8.48e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IL6R—osteoporosis	1.33e-05	8.46e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IGF1—osteoporosis	1.31e-05	8.34e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—LEP—osteoporosis	1.31e-05	8.33e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IRS1—osteoporosis	1.3e-05	8.3e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—IL6—osteoporosis	1.3e-05	8.26e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IRS1—osteoporosis	1.28e-05	8.17e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IRS1—osteoporosis	1.26e-05	8e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—POMC—osteoporosis	1.25e-05	8e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—ESR1—osteoporosis	1.25e-05	7.96e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—POMC—osteoporosis	1.23e-05	7.87e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IL6R—osteoporosis	1.22e-05	7.8e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—IL6—osteoporosis	1.22e-05	7.79e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—POMC—osteoporosis	1.21e-05	7.71e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IGF1—osteoporosis	1.21e-05	7.69e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—IL6—osteoporosis	1.21e-05	7.69e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—IL6—osteoporosis	1.21e-05	7.69e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IL6R—osteoporosis	1.2e-05	7.68e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ENO1—osteoporosis	1.19e-05	7.59e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IGF1—osteoporosis	1.19e-05	7.57e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IL6R—osteoporosis	1.18e-05	7.52e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PSMA2—osteoporosis	1.17e-05	7.48e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PSMA5—osteoporosis	1.17e-05	7.48e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IRS1—osteoporosis	1.17e-05	7.43e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IGF1—osteoporosis	1.16e-05	7.41e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—POMC—osteoporosis	1.12e-05	7.16e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—MYC—osteoporosis	1.11e-05	7.11e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—TGFB1—osteoporosis	1.11e-05	7.09e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—MYC—osteoporosis	1.11e-05	7.06e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—TGFB1—osteoporosis	1.1e-05	7.04e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—IL6—osteoporosis	1.1e-05	7e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IL6R—osteoporosis	1.1e-05	6.98e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—IL6—osteoporosis	1.09e-05	6.94e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—IL6—osteoporosis	1.09e-05	6.93e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—MYC—osteoporosis	1.08e-05	6.91e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—TGFB1—osteoporosis	1.08e-05	6.9e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IGF1—osteoporosis	1.08e-05	6.89e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—IL6—osteoporosis	1.08e-05	6.85e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—MYC—osteoporosis	1.07e-05	6.8e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—TGFB1—osteoporosis	1.06e-05	6.79e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—IL6—osteoporosis	1.05e-05	6.7e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—IL6—osteoporosis	1.05e-05	6.67e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—MYC—osteoporosis	1.02e-05	6.49e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—IL6—osteoporosis	1.02e-05	6.48e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—TGFB1—osteoporosis	1.02e-05	6.48e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—IL6—osteoporosis	1e-05	6.38e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—MYC—osteoporosis	9.61e-06	6.12e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—TGFB1—osteoporosis	9.58e-06	6.11e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CYP19A1—osteoporosis	9.52e-06	6.07e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—MYC—osteoporosis	9.48e-06	6.04e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—MYC—osteoporosis	9.48e-06	6.04e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—TGFB1—osteoporosis	9.46e-06	6.03e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	9.46e-06	6.03e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—IL6—osteoporosis	9.23e-06	5.88e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—IL6—osteoporosis	9.08e-06	5.79e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—IL6—osteoporosis	8.89e-06	5.67e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MYC—osteoporosis	8.64e-06	5.5e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—TGFB1—osteoporosis	8.62e-06	5.49e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MYC—osteoporosis	8.56e-06	5.45e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	8.54e-06	5.44e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MYC—osteoporosis	8.45e-06	5.38e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—TGFB1—osteoporosis	8.43e-06	5.37e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—IL6—osteoporosis	8.38e-06	5.34e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—IL6—osteoporosis	8.33e-06	5.31e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—IL6—osteoporosis	8.26e-06	5.27e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MYC—osteoporosis	8.26e-06	5.27e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—TGFB1—osteoporosis	8.24e-06	5.25e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MYC—osteoporosis	8.22e-06	5.24e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—TGFB1—osteoporosis	8.2e-06	5.23e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—IL6—osteoporosis	8.15e-06	5.2e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—IL6—osteoporosis	8.02e-06	5.11e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MYC—osteoporosis	7.99e-06	5.1e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	7.97e-06	5.08e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MYC—osteoporosis	7.87e-06	5.01e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	7.85e-06	5e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ADCY5—osteoporosis	7.78e-06	4.96e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GPX1—osteoporosis	7.75e-06	4.94e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—IL6—osteoporosis	7.66e-06	4.88e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MYC—osteoporosis	7.25e-06	4.62e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—TGFB1—osteoporosis	7.24e-06	4.61e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IL6—osteoporosis	7.22e-06	4.6e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—MTHFR—osteoporosis	7.16e-06	4.56e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MYC—osteoporosis	7.14e-06	4.55e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IL6—osteoporosis	7.13e-06	4.54e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IL6—osteoporosis	7.13e-06	4.54e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—TGFB1—osteoporosis	7.12e-06	4.54e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MYC—osteoporosis	6.99e-06	4.45e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	6.97e-06	4.44e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MYC—osteoporosis	6.49e-06	4.14e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IL6—osteoporosis	6.49e-06	4.14e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	6.48e-06	4.13e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IL6—osteoporosis	6.43e-06	4.1e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IL6—osteoporosis	6.35e-06	4.05e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IL6—osteoporosis	6.21e-06	3.96e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IL6—osteoporosis	6.18e-06	3.94e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IL6—osteoporosis	6.01e-06	3.83e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IL6—osteoporosis	5.91e-06	3.77e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—POMC—osteoporosis	5.72e-06	3.65e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IL6—osteoporosis	5.45e-06	3.48e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IL6—osteoporosis	5.36e-06	3.42e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IL6—osteoporosis	5.25e-06	3.35e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IL6—osteoporosis	4.88e-06	3.11e-05	CbGpPWpGaD
